The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis

BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is widely used to treat Alzheimer’s Disease. However, the effect of rTMS is still controversial. The purpose of the present study is to evaluate the effectiveness of rTMS on cognitive performance of AD patients.MethodsWe systematically se...

Full description

Bibliographic Details
Main Authors: Zhenyu Wei, Jiaqi Fu, Huazheng Liang, Mingli Liu, Xiaofei Ye, Ping Zhong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.980998/full
_version_ 1811259669357789184
author Zhenyu Wei
Jiaqi Fu
Huazheng Liang
Huazheng Liang
Mingli Liu
Xiaofei Ye
Ping Zhong
Ping Zhong
author_facet Zhenyu Wei
Jiaqi Fu
Huazheng Liang
Huazheng Liang
Mingli Liu
Xiaofei Ye
Ping Zhong
Ping Zhong
author_sort Zhenyu Wei
collection DOAJ
description BackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is widely used to treat Alzheimer’s Disease. However, the effect of rTMS is still controversial. The purpose of the present study is to evaluate the effectiveness of rTMS on cognitive performance of AD patients.MethodsWe systematically searched relevant literatures in four major databases - PubMed, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials [Central] before 28th April 2022. Both randomized controlled trials and cross-section studies that compared the therapeutic effect of rTMS with blank control or sham stimuli were included.ResultsA total of 14 studies involving 513 AD patients were finally included for meta-analysis. It was found that rTMS significantly improved global cognitive function (SMD = 0.24, 95%CI, 0.12 to 0.36, P = 0.0001) and daily living ability (IADL: SMD = 0.64, 95%CI, 0.21to 1.08, P = 0.004) in patients with AD, but did not show improvement in language, memory, executive ability, and mood. In further analyses, rTMS at 10 Hz, on a single target with 20 sessions of treatment was shown to produce a positive effect. In addition, improvement in cognitive functions lasted for at least 6 weeks (SMD = 0.67, 95%CI, 0.05 to 1.30,P = 0.04).ConclusionrTMS can improve the global cognition and daily living ability of AD patients. In addition, attention should be paid to the safety of rTMS in AD patients with seizures. Given the relatively small sample size, our results should be interpreted with caution.
first_indexed 2024-04-12T18:35:00Z
format Article
id doaj.art-975a24c96a82460fae2a36dbe6936ab5
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-04-12T18:35:00Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-975a24c96a82460fae2a36dbe6936ab52022-12-22T03:20:58ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652022-09-011410.3389/fnagi.2022.980998980998The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysisZhenyu Wei0Jiaqi Fu1Huazheng Liang2Huazheng Liang3Mingli Liu4Xiaofei Ye5Ping Zhong6Ping Zhong7Department of Neurology, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, ChinaSchool of Health Science and Engineering, Shanghai University of Science and Technology, Shanghai, ChinaClinical Research Center for Anesthesiology and Perioperative Medicine, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaTranslational Research Institute of Brain and Brain-Like Intelligence, Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Neurology, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, ChinaDepartment of Statistics, Naval Medical University, Shanghai, ChinaDepartment of Neurology, Shidong Hospital Affiliated to University of Shanghai for Science and Technology, Shanghai, ChinaSchool of Health Science and Engineering, Shanghai University of Science and Technology, Shanghai, ChinaBackgroundRepetitive Transcranial Magnetic Stimulation (rTMS) is widely used to treat Alzheimer’s Disease. However, the effect of rTMS is still controversial. The purpose of the present study is to evaluate the effectiveness of rTMS on cognitive performance of AD patients.MethodsWe systematically searched relevant literatures in four major databases - PubMed, EMBASE, Web of Science, and the Cochrane Central Register of Controlled Trials [Central] before 28th April 2022. Both randomized controlled trials and cross-section studies that compared the therapeutic effect of rTMS with blank control or sham stimuli were included.ResultsA total of 14 studies involving 513 AD patients were finally included for meta-analysis. It was found that rTMS significantly improved global cognitive function (SMD = 0.24, 95%CI, 0.12 to 0.36, P = 0.0001) and daily living ability (IADL: SMD = 0.64, 95%CI, 0.21to 1.08, P = 0.004) in patients with AD, but did not show improvement in language, memory, executive ability, and mood. In further analyses, rTMS at 10 Hz, on a single target with 20 sessions of treatment was shown to produce a positive effect. In addition, improvement in cognitive functions lasted for at least 6 weeks (SMD = 0.67, 95%CI, 0.05 to 1.30,P = 0.04).ConclusionrTMS can improve the global cognition and daily living ability of AD patients. In addition, attention should be paid to the safety of rTMS in AD patients with seizures. Given the relatively small sample size, our results should be interpreted with caution.https://www.frontiersin.org/articles/10.3389/fnagi.2022.980998/fullrepetitive transcranial magnetic stimulationAlzheimer’s diseasecognitive functionactivities of daily livingtherapeutic efficacy
spellingShingle Zhenyu Wei
Jiaqi Fu
Huazheng Liang
Huazheng Liang
Mingli Liu
Xiaofei Ye
Ping Zhong
Ping Zhong
The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
Frontiers in Aging Neuroscience
repetitive transcranial magnetic stimulation
Alzheimer’s disease
cognitive function
activities of daily living
therapeutic efficacy
title The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
title_full The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
title_fullStr The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
title_full_unstemmed The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
title_short The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
title_sort therapeutic efficacy of transcranial magnetic stimulation in managing alzheimer s disease a systemic review and meta analysis
topic repetitive transcranial magnetic stimulation
Alzheimer’s disease
cognitive function
activities of daily living
therapeutic efficacy
url https://www.frontiersin.org/articles/10.3389/fnagi.2022.980998/full
work_keys_str_mv AT zhenyuwei thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT jiaqifu thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT huazhengliang thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT huazhengliang thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT mingliliu thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT xiaofeiye thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT pingzhong thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT pingzhong thetherapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT zhenyuwei therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT jiaqifu therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT huazhengliang therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT huazhengliang therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT mingliliu therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT xiaofeiye therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT pingzhong therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis
AT pingzhong therapeuticefficacyoftranscranialmagneticstimulationinmanagingalzheimersdiseaseasystemicreviewandmetaanalysis